What are prednylidene drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

prednylidene drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

prednylidene

0 marketed 1 in Phase 2

This page covers all prednylidene drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 2 pipeline (1)

Dacorsol · Other
Dacorsol is thought to work by interacting with a specific cellular target, although its exact mechanism of action is not well understood.

Patent intelligence

prednylidene patent landscape — aggregated cliff calendar, attackable patents, originator estates